Centene Corporation
NYSE•CNC
執行長: Ms. Sarah M. London
板塊: Healthcare
行業: Medical - Healthcare Plans
上市日期: 2001-12-13
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
聯絡資訊
Centene Plaza, 7700 Forsyth Boulevard, Saint Louis, MO, 63105, United States
314-725-4477
市值
$21.28B
本益比 (TTM)
-3.2
25
股息率
--
52周最高
$66.03
52周最低
$25.08
52周範圍
排名24Top 10.8%
5.7
F-Score
改良版 Piotroski 分析
基於 10 年期基本面
一般 • 5.7 / 9 分
評分區間 (0-9)
8-9: 價值優異
6-7: 基本面強勁
4-5: 整體穩健
0-3: 表現疲弱
資料區間: 2016-2025
財務儀表板
Q4 2025 數據
營業收入
$49.73B+0.00%
近4季度走勢
每股收益
-$2.24+0.00%
近4季度走勢
自由現金流
$224.00M+0.00%
近4季度走勢
2025 Annual 財報亮點
核心亮點
Total Revenue Growth Total revenues reached $194.8 B, a 19% increase, driven by PDP yield, Marketplace growth, and premium tax revenue.
Operating Cash Flow Surge Operating cash flows were $5.1 B, a massive increase from $154 M in 2024, reflecting improved rebate timing.
Medicare Segment Expansion Medicare revenues grew 62% to $37.210 B, primarily driven by increased PDP premium yield and IRA changes.
Improved Expense Ratios SG&A expense ratio improved to 7.4% for 2025, down from 8.5% in 2024, showing cost discipline.
關注風險
Massive Goodwill Impairment Recorded $7.311 B total impairment charges, including $6.7 B goodwill impairment due to OBBBA and stock price decline.
HBR Deterioration Health Benefits Ratio rose to 91.9% from 88.3%, driven by lower Marketplace risk adjustment revenue.
Medicaid Membership Decline Total membership fell 3% to 27.6 M, primarily due to ongoing Medicaid redeterminations following the PHE expiration.
Commercial Margin Pressure Commercial segment gross margin dropped 33% due to lower estimated risk adjustment revenue and increased medical costs.
未來展望
Divestiture Completion Signed agreement to divest remaining Magellan Health businesses in December 2025, streamlining portfolio focus on core managed care.
2026 Rate Adjustments Completed refiling 2026 Marketplace rates to reflect higher projected morbidity baseline and corrective pricing actions.
Future Capital Flow Expecting net dividends of approximately $1.2 B from regulated subsidiaries during 2026 to fund capital expenditures.
D-SNP Integration Focus Continuing enterprise focus on D-SNP opportunity ahead of 2030 mandate for integrated dual-eligible care alignment.
同行對比
營業收入 (TTM)
$194.78B
$45.43B
$22.15B
毛利率 (最新季度)
100.0%
92.3%
90.9%
關鍵指標
股票代碼 | 市值 | 本益比 (TTM) | 股東權益報酬率 (TTM) | 負債率 |
|---|---|---|---|---|
| CNC | $21.28B | -3.2 | -27.7% | 24.2% |
| UTHR | $21.26B | 16.1 | 19.3% | 0.0% |
| THC | $21.22B | 15.1 | 34.8% | 44.4% |
長期趨勢
近4季度
營業收入
淨利
營運現金流
4季度營業收入複合增長率
2.2%
溫和增長
4季度淨利複合增長率
N/M
盈利狀態轉變
現金流穩定性
100%
現金流表現優異
深度研究
下次財報:2026年4月23日
每股收益:-
|營業收入:-
財務數據
電話會議
財務報告
新聞
損益表
資產負債表
現金流量表
財務比率
變化率
損益表 | 過去12個月 |
|---|
無資料